Maria Chiara Bragato

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Ischemia Reperfusion Injury

Top Venues

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Gabriel Méndez-Valdés, Francisca Gómez-Hevia, Maria Chiara Bragato, José Lillo-Moya, Catalina Rojas-Solé, Sarmistha Saha, Ramón Rodrigo
Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Giovanni Paoletti, Jack Pepys, Maria Chiara Bragato, Sandro Paoletti, Alessandra Piona, Maria Rita Messina, Francesca Racca, Sebastian Ferri, Emanuele Nappi, Giovanni Costanzo, Lorenzo Del Moro, Francesca Puggioni, Giorgio Walter Canonica, Elena Azzolini, Enrico Heffler
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital. Vaccines 11 (5) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, Maria Chiara Bragato, José Lillo-Moya, Catalina Rojas-Solé, Sarmistha Saha, Ramón Rodrigo
Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, José Lillo-Moya, Tommy González-Fernández, Joaquin Abelli, Antonia Cereceda-Cornejo, Maria Chiara Bragato, Sarmistha Saha, Ramón Rodrigo
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies. Biomedicines 11 (3) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, Maria Chiara Bragato, José Lillo-Moya, Catalina Rojas-Solé, Sarmistha Saha, Ramón Rodrigo
Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Gabriel Méndez-Valdés, Francisca Gómez-Hevia, José Lillo-Moya, Tommy González-Fernández, Joaquin Abelli, Antonia Cereceda-Cornejo, Maria Chiara Bragato, Sarmistha Saha, Ramón Rodrigo
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies. Biomedicines 11 (3) (2023)